Mar 15 |
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
|
Mar 15 |
Cognition Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
|
Mar 14 |
Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
|
Mar 12 |
Cognition Therapeutics announces pricing of stock offering to raise $11.5M
|
Mar 12 |
Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock
|
Mar 11 |
Cognition Therapeutics looks to raise cash through an equity raise
|
Mar 11 |
Cognition Therapeutics Announces Proposed Public Offering of Common Stock
|
Mar 6 |
Cognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatment Effect of CT1812 in Alzheimer’s Disease Studies
|
Feb 26 |
Cognition Therapeutics to Present at the TD Cowen Health Care Conference
|
Feb 6 |
New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812
|